StonvexLoading…
StonvexStonvexStonvexCore line items from XOM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 | Q3 2022 2022-09-30 | Q2 2022 2022-06-30 |
|---|---|---|---|---|---|
Revenue | $102.71B | $164.44B | $83.64B | $305.51B | $199.00B |
Operating Income | Not available | $28.46B | $16.80B | $58.91B | $33.49B |
Net Income | Not available | $19.31B | $11.43B | $42.99B | $23.33B |
EPS (Diluted) | $3.53 | $4.73 | $2.79 | $10.17 | $5.49 |
Total Assets | Not available | $363.25B | $369.37B | $370.15B | $367.77B |
Total Liabilities | Not available | $156.25B | $162.96B | $177.11B | $183.27B |
Cash & Equivalents | Not available | $29.53B | $32.65B | $30.41B | $18.86B |
Free Cash Flow OCF − CapEx | Not available | $14.95B | $10.93B | $46.55B | $27.00B |
Shares Outstanding | Not available | 4.00B | 4.04B | 4.12B | 4.17B |